Lee Financial CO Abb Vie Inc. Transaction History

Lee Financial CO

$699 Million
Q3 2024

A detailed history of Lee Financial CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Lee Financial CO holds 13,624 shares of ABBV stock, worth $2.39 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

13,624

Previous 12,245 11.26%

Holding current value

$2.39 Million

Previous $2.1 Million 28.1%

% of portfolio

0.38%

Previous 0.34%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $225,935 - $274,876	1,379 Added 11.26%	13,624 $2.69 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $92,719 - $108,275	-599 Reduced 4.66%	12,245 $2.1 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $20,456 - $23,308	-128 Reduced 0.99%	12,844 $2.34 Million
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $14,585 - $16,426	-106 Reduced 0.81%	12,972 $2.01 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $118,227 - $136,865	-885 Reduced 6.34%	13,078 $1.95 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $171,600 - $213,545	-1,295 Reduced 8.49%	13,963 $1.88 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $214,312 - $246,812	-1,482 Reduced 8.85%	15,258 $2.43 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $23,236 - $27,866	168 Added 1.01%	16,740 $2.71 Million
Q3 2022 Nov 01, 2022	BUY	$134.21 - $153.93 $42,544 - $48,795	317 Added 1.95%	16,572 $2.22 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $87,801 - $111,624	-638 Reduced 3.78%	16,255 $2.49 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $228,853 - $283,942	-1,734 Reduced 9.31%	16,893 $2.74 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $13,428 - $16,991	-125 Reduced 0.67%	18,627 $2.52 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $32,664 - $37,079	307 Added 1.66%	18,752 $2.02 Million
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $35,771 - $39,851	-340 Reduced 1.81%	18,445 $2.08 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $34,986 - $38,516	-342 Reduced 1.79%	18,785 $2.03 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $8,531 - $11,519	106 Added 0.56%	19,127 $2.05 Million
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $22,078 - $25,913	257 Added 1.37%	19,021 $1.67 Million
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $10,785 - $14,432	-147 Reduced 0.78%	18,764 $1.84 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $4,257 - $6,454	-66 Reduced 0.35%	18,911 $1.44 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $360 - $451	-5 Reduced 0.03%	18,977 $1.68 Million
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $176,406 - $212,091	2,801 Added 17.31%	18,982 $1.44 Million
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $3,942 - $5,038	-60 Reduced 0.37%	16,181 $1.18 Million
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $12,419 - $14,617	161 Added 1.0%	16,241 $1.31 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $21,486 - $26,498	-276 Reduced 1.69%	16,080 $1.48 Million
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $15,470 - $17,198	-174 Reduced 1.05%	16,356 $1.55 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $40,760 - $48,228	-454 Reduced 2.67%	16,530 $1.53 Million
Q1 2018 May 09, 2018	SELL	$92.01 - $123.21 $204,722 - $274,142	-2,225 Reduced 11.58%	16,984 $1.61 Million
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $35,376 - $38,792	-395 Reduced 2.01%	19,209 $1.86 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $1.37 Million - $1.75 Million	19,604	19,604 $1.74 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

News

Stay updated on Lee Financial CO with notifications on news.

Account